Загрузка...
Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis()
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, progressive and frequently lethal cystic lung disease that almost exclusively affects women and has no proven therapies. An improved understanding of the pathogenesis has identified promising molecular targets for clinical trials. Although barrie...
Сохранить в:
| Опубликовано в: : | Respir Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407662/ https://ncbi.nlm.nih.gov/pubmed/19962873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmed.2009.09.023 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|